Maryland Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Healthcare Reporter.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 10, 2025

November 10, 2025

SpyGlass Pharma Announces Positive 36-Month First-in-Human and 3-Month Phase I/II Trial Results for Its Novel BIM-IOL System

GlobeNewswire

November 10, 2025

ArriVent BioPharma Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 10, 2025

Humacyte Announces Presentation of Positive Two-Year Results from Phase 3 Dialysis Access Trial at the American Society of Nephrology’s Kidney Week 2025

GlobeNewswire

November 10, 2025

Cognitive Training Found Most Effective Lifestyle Intervention to Prevent Cognitive Decline

GlobeNewswire

November 10, 2025

Verrica Pharmaceuticals Presents New Data on VP-315 from its Phase 2 Clinical Trial in Basal Cell Carcinoma at the 40th Society for Immunotherapy of Cancer Annual Meeting

GlobeNewswire

November 10, 2025

Calidi Biotherapeutics Presents New Data on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting and Holds Its First Investor Day at SITC

GlobeNewswire

November 10, 2025

Acumen Pharmaceuticals Appoints George Golumbeski, Ph.D., as Chairman of its Board of Directors

GlobeNewswire

November 10, 2025

Madrigal Presents New Data Demonstrating Rezdiffra® (resmetirom) Significantly Improved Multiple Noninvasive Imaging Tests and Biomarkers in Patients with Compensated MASH Cirrhosis

GlobeNewswire

November 10, 2025

Jasper Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

November 10, 2025

Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity

GlobeNewswire

November 10, 2025

Mersana Therapeutics to Host Third Quarter 2025 Conference Call on November 14, 2025

GlobeNewswire

November 10, 2025

Cingulate Names Industry Veteran Bryan Downey Chief Commercial Officer to Lead Launch Preparation for CTx-1301

GlobeNewswire

November 10, 2025

LifeMD to Participate in the BTIG Digital Health Forum

GlobeNewswire

November 10, 2025

MannKind Provides Update on Phase 3 ICoN-1 Trial of Nebulized Clofazimine for NTM Lung Disease

GlobeNewswire

November 10, 2025

BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities

GlobeNewswire

November 10, 2025

Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market

GlobeNewswire

November 10, 2025

Belite Bio Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

GlobeNewswire

November 10, 2025

Protara Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

November 10, 2025

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 10, 2025

Leading Global Players Back and Fund Pluri’s Cell-Based Food and Agriculture Collaborations

GlobeNewswire